More than 70% of leg ulcers are caused by venous diseases, and their prevalence increases with age. Venous leg ulcers account for most chronic lower-limb wounds observed in primary care, underscoring ...
Austin, April 30, 2026 (GLOBE NEWSWIRE)-- According to SNS Insider, The Wound Debridement Market size is valued at USD 5.16 Billion in 2025 and is projected to reach USD 9.58 Billion by 2035, growing ...
A recent study published in the Journal of Wound Care (UK) has shed light on a revolutionary approach to diabetic foot care that promises hope and relief for millions worldwide. LONDON, England, ...
ON101 (Fespixon, Oneness Biotech), a first-in-class, macrophage-regulating, wound-healing cream for diabetic foot ulcers has shown benefit over absorbent dressings in a phase 3 trial, with another ...
Please provide your email address to receive an email when new articles are posted on . Complete debridement was achieved by 63% of patients treated with EscharEx vs. 30.2% and 13.3% of comparison ...
Ulcers caused by diabetic foot occur in 4% to 10% of patients with diabetes and can lead to limb amputations if left untreated. NPWT, a wound treatment used for open wounds since the 1940s, involves a ...
Diabetic foot complications arise from persistent high blood sugar that damages nerves causing neuropathy and blood vessels leading to peripheral artery disease (PAD). The term diabetic foot disease ( ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results